Eli Lilly and Co
Trump Unveils Game-Changing Deals with Eli Lilly and Novo Nordisk: Reduced Prices on Weight Loss Drugs and Enhanced Medicare Coverage!
President Donald Trump recently made headlines by announcing new agreements with Eli Lilly and Novo Nordisk. These deals aim to ... Read more
Unlocking the Future of Weight Loss: Current Trends and Upcoming Innovations in Blockbuster Medications
The demand for weight-loss and diabetes drugs is booming, and the competition is heating up. Eli Lilly and Novo Nordisk ... Read more
Eli Lilly Surges Past Expectations: Soaring Zepbound and Mounjaro Sales Propel Upgraded Forecast
Eli Lilly’s Profit Surge: A Focus on Growth Amid Competition Eli Lilly recently reported impressive earnings for the third quarter ... Read more
Market Update: Regional Bank Fears Drive Slight Decline in Stock Futures – Get Live Insights!
Traders on the New York Stock Exchange had a rocky Thursday night. U.S. stock futures dipped slightly after a tough ... Read more
Trump’s Pharmaceutical Tariff Threat Dims as Pfizer Deal Reassures Drugmakers: What It Means for the Industry
On September 30, 2025, President Donald Trump made headlines by shaking hands with Pfizer’s CEO, Albert Bourla, to announce a ... Read more
Eli Lilly’s Obesity Pill Beats Novo Nordisk’s Oral Diabetes Drug in Groundbreaking Head-to-Head Trial
Eli Lilly recently announced exciting results for its new diabetes pill, orforglipron. In a recent study, this medication outperformed Novo ... Read more
Eli Lilly Invests $5 Billion in New Virginia Facility to Enhance Production of Targeted Cancer Drugs and Innovative Treatments
Eli Lilly recently announced an impressive $5 billion investment to build a new manufacturing facility in Goochland County, Virginia. This ... Read more
Trump Tariffs Face Supreme Court Showdown: What This Means for the Future of Trade and Legal Battles Ahead
U.S. Treasury Secretary Scott Bessent recently spoke about the ongoing situation with President Trump’s tariffs, emphasizing that even if the ... Read more
Unlocking Tariffs: Why Even a Supreme Court Ruling May Not End the Debate
Scott Bessent, the U.S. Treasury Secretary, recently made headlines as he discussed President Trump’s tariffs. His remarks came amid expectations ... Read more
Why Eli Lilly’s Obesity Pill Is Still a Strong Contender Against Novo’s Wegovy Despite Mixed Investor Reactions
Eli Lilly’s stock has been on a rollercoaster ride recently. It took a hit after the company released data on ... Read more
